Clinical Trial Update: The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing apatinib plus radiotherapy versus apatinib alone for hepatocellular carcinoma with portal vein tumor thrombus (BCLC-C stage I–I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN